NCT00002580View on ClinicalTrials.gov

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

June 30, 1993

Conditions

Breast Cancer

Interventions

DRUG

cyclophosphamide

DRUG

fluorouracil

DRUG

goserelin acetate

DRUG

leuprolide acetate

DRUG

methotrexate

DRUG

tamoxifen citrate

PROCEDURE

conventional surgery

PROCEDURE

laparoscopic surgery

PROCEDURE

oophorectomy

RADIATION

radiation therapy

Trial Locations (10)

LE1 5WW

University Hospitals of Leicester, Leicester

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

DD1 9SY

Ninewells Hospital and Medical School, Dundee

EH4 9NQ

Western General Hospital, Edinburgh

G11 6NT

Beatson Oncology Centre, Glasgow

G61 1BD

University of Glasgow, Glasgow

1V2 3UJ

Raigmore Hospital, Inverness

Unknown

Royal Alexandra Hospital, Paisley

KA6 6DX

Ayr Hospital, Ayr

FK1 5RE

Falkirk Royal Infirmary, Falkirk

All Listed Sponsors

lead

Scottish Cancer Therapy Network

OTHER

NCT00002580 - Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | Biotech Hunter | Biotech Hunter